Recently, there has been increased interest in TRP channels, which are overexpressed and dysregulated in various carcinomas, such as TRPC3 in ovarian cancer [37], TRPC6 in hepatocellular carcinoma [38], TRPM7 in breast cancer [39, 40] and TRPM8 in prostate cancer [41]. This evidence concerns the gene TRPM7 and breast carcinoma.